Publication Name	World Journal of Virology
Manuscript ID	61775
Country	Japan

Received	2020-12-18 06:35
Peer-Review Started	2020-12-18 06:38
To Make the First Decision
Return for Revision	2021-01-07 18:37
Revised	2021-01-16 02:41
Second Decision	2021-02-03 09:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-02-20 05:47
Articles in Press	2021-02-20 05:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-03-13 08:08
Publish the Manuscript Online	2021-03-16 09:17

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza
Manuscript Source	Invited Manuscript
All Author List	Masafumi Seki
Funding Agency and Grant Number
Corresponding Author	Masafumi Seki, MD, Professor, Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University, Fukumuro 1-12-1, Miyagino-ku, Miyagi 983-8536, Japan. m-seki@tohoku-mpu.ac.jp
Key Words	COVID-19; SARS-CoV-2; Influenza; Angiotensin-converting enzyme 2; Vaccine; Alveolar flood
Core Tip	We are focusing the differences and similarity of coronavirus disease 2019 (COVID-19) and Influenza, and review the characteristic pathophysiology and basic concepts of treatment and prevention for COVID-19. Primary influenza pneumonia is known to exist in addition to secondary bacterial pneumonia, however, pulmonary edema (alveolar flood) from a similar cytokine storm, as well as severe angiopathy should be considered in COVID-19.
Publish Date	2021-03-16 09:17
Citation	Seki M. Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza. World J Virol 2021; 10(2): 62-68
URL	https://www.wjgnet.com/2220-3249/full/v10/i2/62.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i2.62

Full Article (PDF)	WJV-10-62.pdf
Full Article (Word)	WJV-10-62.docx
Manuscript File	61775_Auto_Edited_LM.docx
Answering Reviewers	61775-Answering reviewers.pdf
Audio Core Tip	61775-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	61775-Conflict-of-interest statement.pdf
Copyright License Agreement	61775-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	61775-Language certificate.pdf
Peer-review Report	61775-Peer-review(s).pdf
Scientific Misconduct Check	61775-Scientific misconduct check.pdf
Scientific Editor Work List	61775-Scientific editor work list.pdf